Methionine oxidation, α-synuclein and Parkinson's disease

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1703, Issue 2, 2005, Pages 157-169

  Glaser, Charles B ^a   Yamin, Ghiam ^b   Uversky, Vladimir N ^b   Fink, Anthony L ^b  

^a University of California ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Synuclein; Methionine oxidation; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; CYSTEINE; CYTOTOXIC AGENT; HYDROGEN PEROXIDE; METHIONINE; METHIONINE SULFOXIDE; OLIGOMER; TRYPTOPHAN;

AGING; HUMAN; IN VITRO STUDY; NEUROPATHOLOGY; OLIGOMERIZATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN STABILITY; REVIEW; SOLUBILITY;

ALPHA-SYNUCLEIN; HUMANS; METHIONINE; NERVE TISSUE PROTEINS; PARKINSON DISEASE; SYNUCLEINS;

EID: 12844272205     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2004.10.008     Document Type: Review

References (117)

1. M.F. Beal Mitochondria, oxidative damage, and inflammation in Parkinson's disease Ann. N. Y Acad. Sci. 991 2003 120
2. V. Bellotti, P. Mangione, and M. Stoppini Biological activity and pathological implications of misfolded proteins Cell. Mol. Life Sci. 55 1999 977
3. N.F. Bence, R.M. Sampat, and R.R. Kopito Impairment of the ubiquitin-proteasome system by protein aggregation Science 292 2001 1552
4. B.S. Berlett, R.L. Levine, and E.R. Stadtman Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: both modifications mimic effects of adenylylation Proc. Natl. Acad. Sci. U. S. A. 95 1998 2784
5. S. Boschi-Muller, S. Azza, and G. Branlant E. coli methionine sulfoxide reductase with a truncated N terminus or C terminus, or both, retains the ability to reduce methionine sulfoxide Protein Sci. 10 2001 2272
6. E. Cadenas, and K.J. Davies Mitochondrial free radical generation, oxidative stress, and aging Free Radic. Biol Med. 29 2000 222
7. B. Caughey, and P.T. Lansbury Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders Annu. Rev. Neurosci. 26 2003 267
8. B.A. Chromy, R.J. Nowak, M.P. Lambert, K.L. Viola, L. Chang, P.T. Velasco, B.W. Jones, S.J. Fernandez, P.N. Lacor, P. Horowitz, C.E. Finch, G.A. Krafft, and W.L. Klein Self-assembly of Abeta(1-42) into globular neurotoxins Biochemistry 42 2003 12749
9. G. Cohen Oxidative stress, mitochondrial respiration, and Parkinson's disease Ann. N. Y. Acad. Sci. 899 2000 112
10. K.A. Conway, J.C. Rochet, R.M. Bieganski, and P.T. Lansbury Jr. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct Science 294 2001 1346
11. R.A. Crowther, R. Jakes, M.G. Spillantini, and M. Goedert Synthetic filaments assembled from C-terminally truncated alpha-synuclein FEBS Lett. 436 1998 309
12. M. Dahiyat, A. Cumming, C. Harrington, C. Wischik, J. Xuereb, F. Corrigan, G. Breen, D. Shaw, and D. St. Clair Association between Alzheimer's disease and the NOS3 gene Ann. Neurol. 46 1999 664
13. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 2003 819
14. V.L. Dawson, and T.M. Dawson Nitric oxide neurotoxicity J. Chem. Neuroanat. 10 1996 179
15. C.M. Dobson Protein misfolding, evolution and disease Trends Biochem. Sci. 24 1999 329
16. J. Dong, C.S. Atwood, V.E. Anderson, S.L. Siedlak, M.A. Smith, G. Perry, and P.R. Carey Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence Biochemistry 42 2003 2768
17. J.E. Duda, B.I. Giasson, Q. Chen, T.L. Gur, H.I. Hurtig, M.B. Stern, S.M. Gollomp, H. Ischiropoulos, V.M. Lee, and J.Q. Trojanowski Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies Am. J. Pathol. 157 2000 1439
18. M. Ebadi, and S.K. Sharma Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease Antioxid. Redox Signal. 5 2003 319
19. O.M. El Agnaf, and G.B. Irvine Aggregation and neurotoxicity of alpha-synuclein and related peptides Biochem. Soc. Trans. 30 2002 559
20. M.B. Feany, and W.W. Bender A Drosophila model of Parkinson's disease Nature 404 2000 394
21. L.S. Forno Neuropathology of Parkinson's disease J. Neuropathol. Exp. Neurol. 55 1996 259
22. M.W. Foster, and J.S. Stamler New insights into protein S-nitrosylation. Mitochondria as a model system J. Biol. Chem. 279 2004 25891
23. S.P. Gabbita, M.Y. Aksenov, M.A. Lovell, and W.R. Markesbery Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain J. Neurochem. 73 1999 1660
24. J. Gao, D. Yin, Y. Yao, T.D. Williams, and T.C. Squier Progressive decline in the ability of calmodulin isolated from aged brain to activate the plasma membrane Ca-ATPase Biochemistry 37 1998 9536
25. B.I. Giasson, J.E. Duda, I.V. Murray, Q. Chen, J.M. Souza, H.I. Hurtig, H. Ischiropoulos, J.Q. Trojanowski, and V.M. Lee Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions Science 290 2000 985
26. B.I. Giasson, M.S. Forman, M. Higuchi, L.I. Golbe, C.L. Graves, P.T. Kotzbauer, J.Q. Trojanowski, and V.M. Lee Initiation and synergistic fibrillization of tau and alpha-synuclein Science 300 2003 636
27. C.B. Glaser, L. Karic, S. Parmelee, B.R. Premachandra, D. Hinkston, and W.R. Abrams Studies on the turnover of methionine oxidized alpha-1-protease inhibitor in rats Am. Rev. Respir. Dis. 136 1987 857
28. M. Goedert Parkinson's disease and other alpha-synucleinopathies Clin. Chem. Lab Med. 39 2001 308
29. P.F. Good, A. Hsu, P. Werner, D.P. Perl, and C.W. Olanow Protein nitration in Parkinson's disease J. Neuropathol. Exp. Neurol. 57 1998 338
30. S.A. Greenacre, and H. Ischiropoulos Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction Free Radic. Res. 34 2001 541
31. R. Grimaud, B. Ezraty, J.K. Mitchell, D. Lafitte, C. Briand, P.J. Derrick, and F. Barras Repair of oxidized proteins. Identification of a new methionine sulfoxide reductase J. Biol. Chem. 276 2001 48915
32. P. Guptasarma, D. Balasubramanian, S. Matsugo, and I. Saito Hydroxyl radical mediated damage to proteins, with special reference to the crystallins Biochemistry 31 1992 4296
33. A. Hansel, L. Kuschel, S. Hehl, C. Lemke, H.J. Agricola, T. Hoshi, and S.H. Heinemann Mitochondrial targeting of the human peptide methionine sulfoxide reductase (MSRA), an enzyme involved in the repair of oxidized proteins FASEB J. 16 2002 911
34. M. Hashimoto, E. Rockenstein, L. Crews, and E. Masliah Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases Neuromol. Med. 4 2003 21
35. M.J. Hokenson, V.N. Uversky, J. Goers, G. Yamin, L.A. Munishkina, and A.L. Fink Role of individual methionines in the fibrillation of methionine-oxidized alpha-synuclein Biochemistry 43 2004 4621
36. M. Hoshi, M. Sato, S. Matsumoto, A. Noguchi, K. Yasutake, N. Yoshida, and K. Sato Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta Proc. Natl. Acad. Sci. U. S. A. 100 2003 6370
37. H. Ischiropoulos Oxidative modifications of alpha-synuclein Ann. N. Y. Acad. Sci. 991 2003 93
38. H. Ischiropoulos, and J.S. Beckman Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J. Clin. Invest. 111 2003 163
39. J.S. Isenberg, and J.E. Klaunig Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells Toxicol. Sci. 53 2000 340
40. P. Jenner, D.T. Dexter, J. Sian, A.H. Schapira, and C.D. Marsden Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The royal Kings and Queens Parkinson's disease research group Ann. Neurol. 32 1992 S82 S87 (Suppl.)
41. J.A. Johnston, C.L. Ward, and R.R. Kopito Aggresomes: a cellular response to misfolded proteins J. Cell Biol. 143 1998 1883
42. M. Kantorow, J.R. Hawse, T.L. Cowell, S. Benhamed, G.O. Pizarro, V.N. Reddy, and J.F. Hejtmancik Methionine sulfoxide reductase A is important for lens cell viability and resistance to oxidative stress Proc. Natl. Acad. Sci. U. S. A. 101 2004 9654
43. D. Kaur, F. Yantiri, S. Rajagopalan, J. Kumar, J.Q. Mo, R. Boonplueang, V. Viswanath, R. Jacobs, L. Yang, M.F. Beal, D. DiMonte, I. Volitaskis, L. Ellerby, R.A. Cherny, A.I. Bush, and J.K. Andersen Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease Neuron 37 2003 899
44. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486
45. N.P. Kedar Can we prevent Parkinson's and Alzheimer's disease? J. Postgrad. Med. 49 2003 236
46. J.W. Kelly The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways Curr. Opin. Struck. Biol. 8 1998 101
47. W.L. Klein Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets Neurochem. Int. 41 2002 345
48. R.R. Kopito Aggresomes, inclusion bodies and protein aggregation Trends Cell Biol. 10 2000 524
49. R.R. Kopito, and D. Ron Conformational disease Nat. Cell Biol. 2 2000 E207 E209
50. R.J. Krause, S.L. Ripp, P.J. Sausen, L.H. Overby, R.M. Philpot, and A.A. Elfarra Characterization of the methionine S-oxidase activity of rat liver and kidney microsomes: immunochemical and kinetic evidence for FMO3 being the major catalyst Arch. Biochem. Biophys. 333 1996 109
51. S. Krishnan, E.Y. Chi, S.J. Wood, B.S. Kendrick, C. Li, W. Garzon-Rodriguez, J. Wypych, T.W. Randolph, L.O. Narhi, A.L. Biere, M. Citron, and J.F. Carpenter Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis Biochemistry 42 2003 829
52. R. Kruger, W. Kuhn, T. Muller, D. Woitalla, M. Graeber, S. Kosel, H. Przuntek, J.T. Epplen, L. Schols, and O. Riess Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat. Genet. 18 1998 106
53. D.K. Lahiri, D. Chen, Y.W. Ge, M. Farlow, G. Kotwal, A. Kanthasamy, D.K. Ingram, and N.H. Greig Does nitric oxide synthase contribute to the pathogenesis of Alzheimer's disease?: effects of beta-amyloid deposition on NOS in transgenic mouse brain with AD pathology Ann. N. Y. Acad. Sci. 1010 2003 639
54. H.A. Lashuel, D. Hartley, B.M. Petre, T. Walz, and P.T. Lansbury Jr. Neurodegenerative disease: amyloid pores from pathogenic mutations Nature 418 2002 291
55. H.A. Lashuel, B.M. Petre, J. Wall, M. Simon, R.J. Nowak, T. Walz, and P.T. Lansbury Jr. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils J. Mol. Biol. 322 2002 1089
56. C. Levecque, A. Elbaz, J. Clavel, F. Richard, J.S. Vidal, P. Amouyel, C. Tzourio, A. Alperovitch, and M.C. Chartier-Harlin Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study Hum. Mol. Genet. 12 2003 79
57. R.L. Levine, L. Mosoni, B.S. Berlett, and E.R. Stadtman Methionine residues as endogenous antioxidants in proteins Proc. Natl. Acad. Sci. U. S. A. 93 1996 15036
58. M.A. Lovell, C. Xie, S.P. Gabbita, and W.R. Markesbery Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain Free Radic. Biol. Med. 28 2000 418
59. W.T. Lowther, N. Brot, H. Weissbach, J.F. Honek, and B.W. Matthews Thiol-disulfide exchange is involved in the catalytic mechanism of peptide methionine sulfoxide reductase Proc. Natl. Acad. Sci. U. S. A. 97 2000 6463
60. C.B. Lucking, and A. Brice Alpha-synuclein and Parkinson's disease Cell. Mol. Life Sci. 57 2000 1894
61. L. Maroteaux, J.T. Campanelli, and R.H. Scheller Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8 1988 2804
62. E. Masliah, E. Rockenstein, I. Veinbergs, M. Mallory, M. Hashimoto, A. Takeda, Y. Sagara, A. Sisk, and L. Mucke Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders Science 287 2000 1265
63. M.P. Mattson, and W. Duan "Apoptotic" biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders J. Neurosci. Res. 58 1999 152
64. T.A. Mirzabekov, M.C. Lin, and B.L. Kagan Pore formation by the cytotoxic islet amyloid peptide amylin J. Biol. Chem. 271 1996 1988
65. T. Moos, and E.H. Morgan The metabolism of neuronal iron and its pathogenic role in neurological disease: review Ann. N. Y. Acad. Sci. 1012 2004 14
66. J. Moskovitz, S. Bar-Noy, W.M. Williams, J. Requena, B.S. Berlett, and E.R. Stadtman Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals Proc. Natl. Acad. Sci. U. S. A. 98 2001 12920
67. J. Moskovitz, B.S. Berlett, J.M. Poston, and E.R. Stadtman The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo Proc. Natl. Acad. Sci. U. S. A. 94 1997 9585
68. J. Moskovitz, E. Flescher, B.S. Berlett, J. Azare, J.M. Poston, and E.R. Stadtman Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress Proc. Natl. Acad. Sci. U. S. A. 95 1998 14071
69. J. Moskovitz, and E.R. Stadtman Selenium-deficient diet enhances protein oxidation and affects methionine sulfoxide reductase (MsrB) protein level in certain mouse tissues Proc. Natl. Acad. Sci. U. S. A. 100 2003 7486
70. J. Moskovitz, H. Weissbach, and N. Brot Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins Proc. Natl. Acad. Sci. U. S. A. 93 1996 2095
71. J. Moskovitz, M.B. Yim, and P.B. Chock Free radicals and disease Arch. Biochem. Biophys. 397 2002 354
72. H. Naiki, K. Higuchi, M. Hosokawa, and T. Takeda Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T Anal. Biochem. 177 1989 244
73. H. Naiki, K. Higuchi, K. Matsushima, A. Shimada, W.H. Chen, M. Hosokawa, and T. Takeda Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: use of the fluorescent indicator, thioflavine T Lab. Invest. 62 1990 768
74. E.H. Norris, B.I. Giasson, H. Ischiropoulos, and V.M. Lee Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications J. Biol. Chem. 278 2003 27230
75. H. Okazaki, L.E. Lipkin, and S.M. Aronson Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion J. Neuropathol. Exp. Neurol. 20 1961 237
76. S.R. Paik, H.J. Shin, and J.H. Lee Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide Arch. Biochem. Biophys. 378 2000 269
77. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, and R.L. Nussbaum Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045
78. I. Qahwash, K.L. Weiland, Y. Lu, R.W. Sarver, R.F. Kletzien, and R. Yan Identification of a mutant amyloid peptide that predominantly forms neurotoxic protofibrillar aggregates J. Biol. Chem. 278 2003 23187
79. R. Radi Nitric oxide, oxidants, and protein tyrosine nitration Proc. Natl. Acad. Sci. U. S. A. 101 2004 4003
80. J.C. Rochet, and P.T. Lansbury Jr. Amyloid fibrillogenesis: themes and variations Curr. Opin. Struct. Biol. 10 2000 60
81. H. Ruan, X.D. Tang, M.L. Chen, M.L. Joiner, G. Sun, N. Brot, H. Weissbach, S.H. Heinemann, L. Iverson, C.F. Wu, T. Hoshi, M.L. Chen, M.A. Joiner, and S.H. Heinemann High-quality life extension by the enzyme peptide methionine sulfoxide reductase Proc. Natl. Acad. Sci. U. S. A. 99 2002 2748
82. C. Schoneich, D. Pogocki, G.L. Hug, and K. Bobrowski Free radical reactions of methionine in peptides: mechanisms relevant to beta-amyloid oxidation and Alzheimer's disease J. Am. Chem. Soc. 125 2003 13700
83. B.R. Sellman, B.L. Kagan, and R.K. Tweten Generation of a membrane-bound, oligomerized pre-pore complex is necessary for pore formation by Clostridium septicum alpha toxin Mol. Microbiol. 23 1997 551
84. L.C. Serpell, J. Berriman, R. Jakes, M. Goedert, and R.A. Crowther Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation Proc. Natl. Acad. Sci. U. S. A. 97 2000 4897
85. V.S. Sharov, D.A. Ferrington, T.C. Squier, and C. Schoneich Diastereoselective reduction of protein-bound methionine sulfoxide by methionine sulfoxide reductase FEBS Lett. 455 1999 247
86. V.S. Sharov, and C. Schoneich Diastereoselective protein methionine oxidation by reactive oxygen species and diastereoselective repair by methionine sulfoxide reductase Free Radic. Biol. Med. 29 2000 986
87. A.B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, M. Hulihan, T. Peuralinna, A. Dutra, R. Nussbaum, S. Lincoln, A. Crawley, M. Hanson, D. Maraganore, C. Adler, M.R. Cookson, M. Muenter, M. Baptista, D. Miller, J. Blancato, J. Hardy, and K. Gwinn-Hardy Alpha-synuclein locus triplication causes Parkinson's disease Science 302 2003 841
88. E.P. Skaar, D.M. Tobiason, J. Quick, R.C. Judd, H. Weissbach, F. Etienne, N. Brot, and H.S. Seifert The outer membrane localization of the Neisseria gonorrhoeae MsrA/B is involved in survival against reactive oxygen species Proc. Natl. Acad. Sci. U. S. A. 99 2002 10108
89. A. Spector, R. Scotto, H. Weissbach, and N. Brot Lens methionine sulfoxide reductase Biochem. Biophys. Res. Commun. 108 1982 429
90. M.G. Spillantini, R.A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert a-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies Proc Natl Acad Sci. U. S. A. 95 1998 6469
91. T.C. Squier Oxidative stress and protein aggregation during biological aging Exp. Gerontol. 36 2001 1539
92. E.R. Stadtman Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions Annu. Rev. Biochem. 62 1993 797
93. E.R. Stadtman Protein oxidation in aging and age-related diseases Ann. N. Y. Acad. Sci. 928 2001 22
94. E.R. Stadtman, J. Moskovitz, B.S. Berlett, and R.L. Levine Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism Mol. Cell. Biochem. 234-235 2002 3
95. E.R. Stadtman, C.N. Oliver, P.E. Starke-Reed, and S.G. Rhee Age-related oxidation reaction in proteins Toxicol. Ind. Health 9 1993 187
96. V.V. Sumbayev S-nitrosylation of thioredoxin mediates activation of apoptosis signal-regulating kinase 1 Arch. Biochem. Biophys. 415 2003 133
97. H. Sun, J. Gao, D.A. Ferrington, H. Biesiada, T.D. Williams, and T.C. Squier Repair of oxidized calmodulin by methionine sulfoxide reductase restores ability to activate the plasma membrane Ca-ATPase Biochemistry 38 1999 105
98. A. Takeda, M. Mallory, M. Sundsmo, W. Honer, L. Hansen, and E. Masliah Abnormal accumulation of NACP/a-Synuclein in neurodegenerative disorders Am. J. Pathol. 152 1998 367
99. M. Tien, B.S. Berlett, R.L. Levine, P.B. Chock, and E.R. Stadtman Peroxynitrite-mediated modification of proteins at physiological carbon dioxide concentration: pH dependence of carbonyl formation, tyrosine nitration, and methionine oxidation Proc. Natl. Acad. Sci. U. S. A. 96 1999 7809
100. J.Q. Trojanowski, M. Goedert, T. Iwatsubo, and V.M. Lee Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia Cell Death Differ. 5 1998 832
101. J.Q. Trojanowski, and V.M. Lee Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses Ann. N. Y. Acad. Sci. 991 2003 107
102. K. Ueda, H. Fukushima, E. Masliah, Y. Xia, A. Iwai, M. Yoshimoto, D.A. Otero, J. Kondo, Y. Ihara, and T. Saitoh Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 90 1993 11282
103. V.N. Uversky, J.R. Gillespie, A. Talapatra, and A.L. Fink Protein deposits as the molecular basis of amyloidosis: Part I. Systemic amyloidosis Med. Sci. Monit. 5 1999 1001
104. V.N. Uversky, J. Li, and A.L. Fink Evidence for a partially folded intermediate in alpha-synuclein fibril formation J. Biol. Chem. 276 2001 10737
105. V.N. Uversky, J. Li, and A.L. Fink Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular link between Parkinson's disease and heavy metal exposure J. Biol. Chem. 276 2001 44284
106. V.N. Uversky, J. Li, P.O. Souillac, I.S. Millett, S. Doniach, R. Jakes, M. Goedert, and A.L. Fink Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins J. Biol. Chem. 277 2002 11970
107. V.N. Uversky, G. Yamin, P.O. Souillac, J. Goers, C.B. Glaser, and A.L. Fink Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro FEBS Lett. 517 2002 239
108. W. Vogt Oxidation of methionyl residues in proteins: tools, targets, and reversal Free Radic. Biol. Med. 18 1995 93
109. M.J. Volles, and P.T. Lansbury Jr. Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism Biochemistry 41 2002 4595
110. S. Vougier, J. Mary, and B. Friguet Subcellular localization of methionine sulphoxide reductase A (MsrA): evidence for mitochondrial and cytosolic isoforms in rat liver cells Biochem. J. 373 2003 531
111. P.H. Weinreb, W. Zhen, A.W. Poon, K.A. Conway, and P.T. Lansbury Jr. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded Biochemistry 35 1996 13709
112. S.J. Wood, J. Wypych, S. Steavenson, J.C. Louis, M. Citron, and A.L. Biere Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease J. Biol. Chem. 274 1999 19509
113. G. Yamin, C.B. Glaser, V.N. Uversky, and A.L. Fink Certain metals trigger fibrillation of methionine-oxidized {alpha}-synuclein J. Biol. Chem. 278 2003 27630
114. G. Yamin, V.N. Uversky, and A.L. Fink Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers FEBS Lett. 542 2003 147
115. O. Yermolaieva, R. Xu, C. Schinstock, N. Brot, H. Weissbach, S.H. Heinemann, and T. Hoshi Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation Proc. Natl. Acad. Sci. U. S. A. 101 2004 1159
116. J.J. Zarranz, J. Alegre, J.C. Gomez-Esteban, E. Lezcano, R. Ros, I. Ampuero, L. Vidal, J. Hoenicka, O. Rodriguez, B. Atares, V. Llorens, T.E. Gomez, T. del Ser, D.G. Munoz, and J.G. de Yebenes The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann. Neurol. 55 2004 164
117. M. Zhu, J. Li, and A.L. Fink The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation J. Biol. Chem. 278 2003 40186